R.P. Robinson
Pfizer Global Research & Development
Groton Laboratories
CT 06340
USA
Name/email consistency: high
- Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors. Robinson, R.P., Laird, E.R., Donahue, K.M., Lopresti-Morrow, L.L., Mitchell, P.G., Reese, M.R., Reeves, L.M., Rouch, A.I., Stam, E.J., Yocum, S.A. Bioorg. Med. Chem. Lett. (2001)
- Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffold. Robinson, R.P., Laird, E.R., Blake, J.F., Bordner, J., Donahue, K.M., Lopresti-Morrow, L.L., Mitchell, P.G., Reese, M.R., Reeves, L.M., Stam, E.J., Yocum, S.A. J. Med. Chem. (2000)